9-113393524-G-C

Variant summary

Our verdict is Likely pathogenic. The variant received 7 ACMG points: 7P and 0B. PS3PM2PP5

The NM_001003945.3(ALAD):​c.-44C>G variant causes a 5 prime UTR premature start codon gain change. The variant allele was found at a frequency of 0.0000812 in 1,613,876 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). ClinVar reports functional evidence for this variant: "SCV000491332: Published functional studies demonstrate that the p.(F12L) variant results in ALAD protein without significant enzyme activity (Maruno et al., 2001" and additional evidence is available in ClinVar.

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000085 ( 0 hom. )

Consequence

ALAD
NM_001003945.3 5_prime_UTR_premature_start_codon_gain

Scores

5
9
4

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:2U:1

Conservation

PhyloP100: 3.88

Publications

28 publications found
Variant links:
Genes affected
ALAD (HGNC:395): (aminolevulinate dehydratase) The ALAD enzyme is composed of 8 identical subunits and catalyzes the condensation of 2 molecules of delta-aminolevulinate to form porphobilinogen (a precursor of heme, cytochromes and other hemoproteins). ALAD catalyzes the second step in the porphyrin and heme biosynthetic pathway; zinc is essential for enzymatic activity. ALAD enzymatic activity is inhibited by lead and a defect in the ALAD structural gene can cause increased sensitivity to lead poisoning and acute hepatic porphyria. Alternative splicing of this gene results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2015]
ALAD Gene-Disease associations (from GenCC):
  • porphyria due to ALA dehydratase deficiency
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_pathogenic. The variant received 7 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV000491332: Published functional studies demonstrate that the p.(F12L) variant results in ALAD protein without significant enzyme activity (Maruno et al., 2001; Akagi et al., 1999; Inoue et al., 2008; Akagi et al., 2006)
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 9-113393524-G-C is Pathogenic according to our data. Variant chr9-113393524-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 16867.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001003945.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALAD
NM_000031.6
MANE Select
c.36C>Gp.Phe12Leu
missense
Exon 2 of 12NP_000022.3
ALAD
NM_001003945.3
c.-44C>G
5_prime_UTR_premature_start_codon_gain
Exon 2 of 12NP_001003945.1P13716-2
ALAD
NM_001317745.2
c.63C>Gp.Phe21Leu
missense
Exon 2 of 11NP_001304674.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALAD
ENST00000409155.8
TSL:1 MANE Select
c.36C>Gp.Phe12Leu
missense
Exon 2 of 12ENSP00000386284.3P13716-1
ALAD
ENST00000907374.1
c.36C>Gp.Phe12Leu
missense
Exon 2 of 12ENSP00000577433.1
ALAD
ENST00000907359.1
c.36C>Gp.Phe12Leu
missense
Exon 2 of 12ENSP00000577418.1

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152236
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000279
AC:
7
AN:
251014
AF XY:
0.0000221
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000441
Gnomad OTH exome
AF:
0.000327
GnomAD4 exome
AF:
0.0000848
AC:
124
AN:
1461640
Hom.:
0
Cov.:
31
AF XY:
0.0000715
AC XY:
52
AN XY:
727092
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33466
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86238
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53418
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5580
European-Non Finnish (NFE)
AF:
0.000109
AC:
121
AN:
1112010
Other (OTH)
AF:
0.0000331
AC:
2
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
6
12
19
25
31
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152236
Hom.:
0
Cov.:
31
AF XY:
0.0000403
AC XY:
3
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41474
American (AMR)
AF:
0.0000654
AC:
1
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5200
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68036
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000453
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.0000330
AC:
4
EpiCase
AF:
0.000109
EpiControl
AF:
0.000178

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
1
-
not provided (2)
1
-
-
PORPHYRIA, ACUTE HEPATIC, DIGENIC (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.89
BayesDel_addAF
Pathogenic
0.27
D
BayesDel_noAF
Pathogenic
0.31
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.74
D
Eigen
Benign
0.12
Eigen_PC
Benign
0.20
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Pathogenic
0.99
D
M_CAP
Uncertain
0.15
D
MetaRNN
Uncertain
0.65
D
MetaSVM
Uncertain
0.19
D
MutationAssessor
Uncertain
2.8
M
PhyloP100
3.9
PrimateAI
Uncertain
0.68
T
PROVEAN
Uncertain
-2.8
D
REVEL
Pathogenic
0.66
Sift
Benign
0.69
T
Sift4G
Benign
0.66
T
Polyphen
0.025
B
Vest4
0.82
MutPred
0.48
Gain of helix (P = 0.0117)
MVP
0.90
MPC
0.77
ClinPred
0.85
D
GERP RS
3.8
Varity_R
0.34
gMVP
0.76
Mutation Taster
=13/87
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs121912984; hg19: chr9-116155804; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.